Company intelligence / Profile preview

Weilos

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Weilos was a digital health company that provided a social weight loss platform centered on peer-to-peer support and visual progress tracking. The mobile application allowed users to share "before and after" photos and connect with others to maintain motivation and accountability during their weight loss journeys. By leveraging social networking dynamics, Weilos aimed to improve the success rates of individuals attempting to lose weight through behavioral change. The company was acquired by Weight Watchers (now WW International) in 2015 to integrate its social features into the larger Weight Watchers digital ecosystem.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Weilos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weilos.

Explore the full profile